510(k) Report

510(k) · Cleared

Cleared

GenePOC Strep A

K183366510(k) TraditionalCleared Mar 6, 201992-day reviewClass II21 CFR 866.2680

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Genepoc, Inc. · PGX Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System

Cleared on Mar 6, 2019 after a 92-day review. The FDA summary names no predicate by number.

Decided
Mar 6, 2019
Review
92 days
Class
Class II
Product code
PGX
Recalls
None
Predicates
0

The FDA summary names no predicate by number.

FIG. 1 — Lineage of K183366Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PGX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PGX device

  1. #1 K260047 cobas Strep A Nucleic acid test for use on the…score 14.0 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PGX devices

PGX Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · PGX

1in 2020

2014: 32015: 32016: 12017: 22018: 22019: 12020: 12026 (partial year): 2
2007high 3 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PGX

85in 2015

2015: 85 days median
2007high 85 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PGX

2in 2023

2023: 2
2007high 2 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PGX

1in 2022

2019: 22022: 1
2007high 2 (2019) · low 0 (2007)2025

MAUDE reports naming product code PGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20143—00
201538500
20161—00
20172—00
20182—00
20191—02
20201—00
20210—00
20220—01
20230—20
20240—00
20250—00
20262—0—
Cite this page

510(k) Report. “K183366: GenePOC Strep A.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K183366

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026